Insights

AI powered expansion Zealand Pharma is actively expanding beyond peptide-focused programs through partnerships with Generate Biomedicines to apply AI-enabled protein design for obesity and metabolic diseases, signaling opportunities to offer data, analytics, and computational collaboration services to accelerate drug development timelines.

Obesity programs scale Leading obesity initiatives are backed by major partners Roche and Boehringer Ingelheim, with ongoing collaboration around petrelintide and a multi-billion potential deal in play, indicating a strong market pull and co-development opportunities to offer specialty manufacturing, biospecimen analytics, or clinical trial support services.

Hybrid modalities push New Massachusetts research hub signals Zealand’s move into hybrid modalities beyond peptides, creating doors for cross-portfolio partnerships in protein therapeutics, translational science, and contract research or manufacturing collaborations with a focus on scalable production and regulatory readiness.

Massachusetts gateway Opening a Cambridge-based research hub expands geographical proximity to pharma ecosystems, enabling targeted outreach to biotech entities, CROs, and startups in the Boston ecosystem for collaboration, licensing conversations, and joint development programs.

Strategic collaborations The multi-party licensing and collaboration activity around obesity and AI-enabled protein therapeutics indicates robust demand for strategic alliances; sales opportunities exist in licensing negotiations, co-development services, and commercialization support across regulatory, clinical, and market access functions.

Similar companies to Zealand Pharma

Zealand Pharma Tech Stack

Zealand Pharma uses 8 technology products and services including MATLAB, iCIMS, GitHub, and more. Explore Zealand Pharma's tech stack below.

Media & News

Zealand Pharma's Email Address Formats

Zealand Pharma uses at least 4 email formats:
Zealand Pharma Email FormatsExamplePercentage
FLast@zealandpharma.comJDoe@zealandpharma.com
78%
First.Last@zealandpharma.comJohn.Doe@zealandpharma.com
13%
FMLast@zealandpharma.comJMDoe@zealandpharma.com
5%
FL@zealandpharma.comJD@zealandpharma.com
4%

Frequently Asked Questions

What is Zealand Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Zealand Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Zealand Pharma's stock symbol?

Minus sign iconPlus sign icon
Zealand Pharma is a publicly traded company; the company's stock symbol is ZEAL.

What is Zealand Pharma's official website and social media links?

Minus sign iconPlus sign icon
Zealand Pharma's official website is zealandpharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Zealand Pharma generate?

Minus sign iconPlus sign icon
As of October 2026, Zealand Pharma's annual revenue is estimated to be $25M - $50M.

What is Zealand Pharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
Zealand Pharma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Zealand Pharma have currently?

Minus sign iconPlus sign icon
As of October 2026, Zealand Pharma has approximately 640 employees across 4 continents, including Europe, North America and Asia. Key team members include Ceo: D. S., Cfo: J. D. H. and Chief Scientific Officer: U. S. Explore Zealand Pharma's employee directory with LeadIQ.

What industry does Zealand Pharma belong to?

Minus sign iconPlus sign icon
Zealand Pharma operates in the Biotechnology Research industry.

What technology does Zealand Pharma use?

Minus sign iconPlus sign icon
Zealand Pharma's tech stack includes MATLAB, iCIMS, GitHub, HashiCorp Terraform, SAP, Microsoft Active Directory, Cisco and Coupa.

What is Zealand Pharma's email format?

Minus sign iconPlus sign icon
Zealand Pharma's email format typically follows the pattern of FLast@zealandpharma.com. Find more Zealand Pharma email formats with LeadIQ.

How much funding has Zealand Pharma raised to date?

Minus sign iconPlus sign icon
As of October 2026, Zealand Pharma has raised $1.6B in funding. The last funding round occurred on Jun 06, 2025 for $4.1M.

When was Zealand Pharma founded?

Minus sign iconPlus sign icon
Zealand Pharma was founded in 1998.
Zealand Pharma logo

Zealand Pharma

Biotechnology ResearchHovedstaden, Denmark501-1000 Employees

It advances its obesity programs through collaborations, including partnerships with Roche and Boehringer Ingelheim. It is based in Søborg, in the Capital Region of Denmark, and maintains a team in the United States. In June 2026, the company participated in the American Diabetes Association conference.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ZEAL
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
501-1000

Section iconFunding & Financials

  • $1.6B

    Zealand Pharma has raised a total of $1.6B of funding over 8 rounds. Their latest funding round was raised on Jun 06, 2025 in the amount of $4.1M as a Post IPO Equity.

  • $25M - $50M

    Zealand Pharma's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.